Press Releases

In The Beat Newsletter

Sign up for the CANet monthly newsletter to stay informed with our Networks activities.

Media Inquiries

Fabian Folias
Director, Digital Marketing and Communications
media@canet-nce.ca
519-661-2111 x81353

  

We are pleased to match Baylis’ investment to accelerate the development and commercialization of the first-in-Canada medical devices that will be used by doctors during heart procedures. Such innovative and transformative products are expanding international markets for made-in-Canada technologies that have a positive impact on patients around the world.

Honourable Navdeep Bains
Minister of Innovation, Science and Economic Development and Minister, FedDev Ontario

Media Releases

Important Announcements

05
Nov

Randomized Controlled Trial Finds NRG® Transseptal Needle Leads to Shorter Procedure Times, Reduced Radiation Exposure

TORONTO, NOVEMBER 5, 2019 – A randomized controlled trial has found that use of Baylis Medical’s NRG® Transseptal Needle results in shorter time in achieving transseptal access, less transseptal attempts, and reduced exposure to radiation, compared to use of a conventional transseptal needle. The study, entitled Randomized Trial of Conventional Versus Radiofrequency Needle Transseptal Puncture...
Read More
01
Feb

CANet VIRTUES: cutting-edge technology ushers in a bold new era of arrhythmia care

London, ON, February 1, 2019 — Cardiac Arrhythmia Network of Canada (CANet) leverages cutting edge technology to empower its patients. Digital innovations like artificial intelligence, blockchain technology, and consumer-grade wearables are now mainstream. Healthcare services must invest in these breakthroughs to deliver better medical care for Canadians. CANet is currently focusing on solutions – advanced...
Read More
11
Jun

‘CASMER’ Launched in Alberta – Reducing Canadian Healthcare Costs by Eliminating Syncope Hospitalizations

Calgary, AB, June 11, 2018 – Paramedics in Calgary and surrounding areas are now able to increase capacity in the Emergency Medical Services (EMS) system, thanks to the CANet-funded project, CASMER, Community Alternatives for Syncope Management in the Emergency Room. CANet investigator, CASMER project lead and professor at University of Calgary’s Faculty of Medicine Dr....
Read More
16
Feb

CANet, partners fund over $14 million in arrhythmia research

London, ON, February 16, 2018 — The Cardiac Arrhythmia Network of Canada (CANet) and its partners are pleased to announce funding of 10 research grants totaling over $4.4 million with an additional $10 million in matching funds. With this funding cycle, CANet continues to grow in scale and scope. The introduction of a dedicated Social...
Read More
28
Sep

Baylis Medical teams with National Centre of Excellence to improve the lives of people with atrial fibrillation

More physicians will soon be evaluating an innovative radio frequency (RF) needle developed by Baylis Medical Company Inc. as part of a cross-Canada clinical trial in people with atrial fibrillation (AF). It is the most common heart arrhythmia abnormality and accounts for the majority of arrhythmia-related emergency room visits and hospital admissions. Previous studies have...
Read More

Need More Info?

Have a story to share?


Yes, please subscribe me to the CANet newsletter